CROSSJECT (EPA:ALCJ) | WebDisclosure

Basculer en Français

11144	Companies
245611	Keywords
173686	Articles
132561	Press releases

Home
Companies
CROSSJECT

PRESS RELEASE

published on 03/25/2025 at 07:30, 1 year 6 months ago

CROSSJECT fait le point sur sa collaboration avec ETON PHARMACEUTICALS, Inc. et sur le programme ZENEO® Hydrocortisone dans le domaine de l'insuffisance surrénale
CROSSJECT renforce sa collaboration avec ETON PHARMACEUTICALS pour le programme ZENEO® Hydrocortisone dans l'insuffisance surrénale, avec des depôts de dossiers prévus à partir de S2 2026

Collaboration Eton Pharmaceuticals Crossject Insuffisance Surrénale ZENEO® Hydrocortisone
PRESS RELEASE

published on 03/25/2025 at 07:30, 1 year 6 months ago

CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency program
CROSSJECT enhances collaboration with ETON PHARMACEUTICALS Inc. on ZENEO adrenal insufficiency program, introducing new hydrocortisone formulation for the hospital market

Eton Pharmaceuticals Crossject Hydrocortisone Adrenal Insufficiency ZENEO
BRIEF

published on 03/10/2025 at 14:22, 1 year 6 months ago

Crossject : Mise à jour sur les droits de vote et actions au 31 janvier 2025

Droits De Vote Capital Social Actions Pharmaceutique Crossject
BRIEF

published on 03/10/2025 at 14:22, 1 year 6 months ago

Crossject: Update on voting rights and shares as of January 31, 2025

Share Capital Voting Rights Actions Pharmaceutical Crossject
PRESS RELEASE

published on 03/10/2025 at 14:17, 1 year 6 months ago

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social
Crossject communique le nombre total de droits de vote et d’actions composant son capital social au 31 janvier 2025, conformément aux règlements de l’AMF et du Code de commerce

Droits De Vote Capital Social Pharmaceutique Communiqué Crossject
BRIEF

published on 02/12/2025 at 07:35, 1 year 7 months ago

Crossject Reappoints Key Members to Executive Board

Executive Board Crossject ZEPIZURE® Reappointment Needle-free Technology
BRIEF

published on 02/12/2025 at 07:35, 1 year 7 months ago

Crossject renouvelle le mandat de membres clés de son conseil d'administration

Conseil Exécutif Crossject ZEPIZURE® Renouvellement De Nomination Technologie Sans Aiguille
PRESS RELEASE

published on 02/12/2025 at 07:30, 1 year 7 months ago

Crossject announces the reappointment of Patrick Alexandre and Isabelle Liebschutz as members of new, streamlined Executive Board
Crossject reappoints Patrick Alexandre and Isabelle Liebschutz to its Executive Board, focusing on final stages of ZEPIZURE registration with the FDA

Executive Board Crossject Patrick Alexandre Isabelle Liebschutz ZEPIZURE Registration
PRESS RELEASE

published on 02/12/2025 at 07:30, 1 year 7 months ago

Crossject annonce le renouvellement de Patrick Alexandre et Isabelle Liebschutz dans leurs fonctions de membres d’un nouveau Directoire ressérré
Crossject renouvelle Patrick Alexandre et Isabelle Liebschutz au sein d'un nouveau Directoire resserré pour se concentrer sur l'enregistrement du ZEPIZURE® auprès de la FDA et la commercialisation aux Etats-Unis

FDA Renouvellement Crossject ZEPIZURE® Directoire
BRIEF

published on 02/06/2025 at 07:35, 1 year 8 months ago

Modification des Obligations Convertibles par Crossject

Financement Obligations Convertibles Crossject ZEPIZURE Heights Capital

Accesswire

Published on 10/07/2026 at 22:05, 10 minutes ago

Loar Holdings Inc. Announces Date and Time for Third Quarter 2026 Earnings and Conference Call
Published on 10/07/2026 at 17:00, 5 hours 15 minutes ago

BlackBerry Radar Expands Asset Intelligence Platform with Dynamic Pairing
Published on 10/07/2026 at 15:30, 6 hours 45 minutes ago

Gold Port Announces Marketing Agreement with NAI Interactive Ltd.
Published on 10/07/2026 at 14:30, 7 hours 45 minutes ago

Secure Blockchain's Agentic Solutions Signs Financial Services Firm, Expanding Enterprise AI Into Corporate Finance
Published on 10/07/2026 at 13:33, 8 hours 42 minutes ago

BULGOLD Samples 21.2g/t Gold at Surface and Expands Kopernica Footprint by 170% to 1,700 Metres by 800 Metres, Lutila Project

View all ACCESSWIRE

EQS Group

Published on 10/07/2026 at 22:00, 15 minutes ago

Invitation - Q3 2026 Trading Update Conference Call
Published on 10/07/2026 at 21:35, 40 minutes ago

OCI N.V. Notes Enterprise Chamber Decision Not to Order Inquiry
Published on 10/07/2026 at 20:55, 1 hour 20 minutes ago

innoscripta SE Initiates Independent External Investigations to Clarify the Facts Underlying the Authorities’ Investigations and Review Clusterix’s Documentation and Control Mechanisms
Published on 10/07/2026 at 18:30, 3 hours 45 minutes ago

IEVA GROUP: rappel – Visioconference actionnaires et investisseurs jeudi 15 octobre 2026 - 18h00 (CEST)
Published on 10/07/2026 at 18:15, 4 hours ago

VAZIVA SA: 2026 HALF-YEAR RESULTS - A half-year of strategic investments to prepare a new growth cycle

Les Echos

Published on 10/07/2026 at 20:15, 2 hours ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 10/07/2026 at 20:15, 2 hours ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 10/07/2026 at 20:15, 2 hours ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES SEPTEMBRE 2026
Published on 10/07/2026 at 20:15, 2 hours ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES SEPTEMBRE 2026
Published on 10/07/2026 at 18:19, 3 hours 55 minutes ago

Outstanding shares and voting rights statement at 30 September 2026

View all LES ECHOS COMFI WIRE